Biosimilar Patent Litigation Bill Would Change BPCIA Strategy
At a hearing on June 27, 2019, the Senate Judiciary Committee passed four separate bills aimed at pharmaceutical competition and pricing issues. One of those bills, the Affordable Prescriptions for Patients...To view the full article, register now.
Already a subscriber? Click here to view full article